Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bladder Cancer

  Free Subscription


21.06.2021

2 Aktuelle Urol
1 Arch Biochem Biophys
1 Bioengineered
1 Cell Death Differ
1 Clin Cancer Res
1 Clin Genitourin Cancer
1 Cochrane Database Syst Rev
1 Dis Markers
1 Eur Radiol
1 Eur Urol Focus
1 Front Genet
4 Front Oncol
1 Front Surg
2 Int J Clin Pract
1 Intern Med
3 J Cancer Res Ther
1 JGH Open
1 Nitric Oxide
1 Scand J Urol
1 Urology
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aktuelle Urol

  1. REXER H, Kubler H, Retz M

    Aktuelle Urol. 2021;52:220-221.
    PubMed        

  2. LAMPEL A, Schultz-Lampel D
    [Urinary diversion after uro-oncologic interventions in women: the right procedure for the right patient].
    Aktuelle Urol. 2021;52:268-275.
    PubMed         Abstract available


    Arch Biochem Biophys

  3. SHI S, Ma T, Xi Y
    Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy.
    Arch Biochem Biophys. 2021;708:108950.
    PubMed         Abstract available


    Bioengineered

  4. LIN G, Zhang J, Wu Y, Zhu S, et al
    Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer.
    Bioengineered. 2021;12:2649-2663.
    PubMed         Abstract available


    Cell Death Differ

  5. DENG G, Wang R, Sun Y, Huang CP, et al
    Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARgamma/MMP-9 signals.
    Cell Death Differ. 2021 Jun 14. pii: 10.1038/s41418-021-00743.
    PubMed         Abstract available


    Clin Cancer Res

  6. DAMRAUER JS, Roell KR, Smith MA, Sun X, et al
    Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of bacillus Calmette-Guerin immunotherapy in non-muscle invasive bladder cancer.
    Clin Cancer Res. 2021 Jun 11. pii: 1078-0432.CCR-21-0205.
    PubMed         Abstract available


    Clin Genitourin Cancer

  7. KIM JI, Zhu D, Barry E, Kovac E, et al
    Intravesical Bacillus Calmette-Guerin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2021 May 17. pii: S1558-7673(21)00096.
    PubMed         Abstract available


    Cochrane Database Syst Rev

  8. HAN MA, Maisch P, Jung JH, Hwang JE, et al
    Intravesical gemcitabine for non-muscle invasive bladder cancer.
    Cochrane Database Syst Rev. 2021;6:CD009294.
    PubMed         Abstract available


    Dis Markers

  9. DONG D, Yao Y, Song J, Sun L, et al
    Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy.
    Dis Markers. 2021;2021:6645220.
    PubMed         Abstract available


    Eur Radiol

  10. KIMURA K, Yoshida S, Tsuchiya J, Yamada I, et al
    Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer.
    Eur Radiol. 2021 Jun 13. pii: 10.1007/s00330-021-08110.
    PubMed         Abstract available


    Eur Urol Focus

  11. LAUKHTINA E, Rajwa P, Mori K, Moschini M, et al
    Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    Eur Urol Focus. 2021 Jun 11. pii: S2405-4569(21)00162.
    PubMed         Abstract available


    Front Genet

  12. ZHANG F, Wang X, Bai Y, Hu H, et al
    Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
    Front Genet. 2021;12:670384.
    PubMed         Abstract available


    Front Oncol

  13. ZHOU Z, Cui Y, Huang S, Chen Z, et al
    The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study.
    Front Oncol. 2021;11:651657.
    PubMed         Abstract available

  14. ZANG J, Ye K, Fei Y, Zhang R, et al
    Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis.
    Front Oncol. 2021;11:696716.
    PubMed         Abstract available

  15. BOGEN JP, Grzeschik J, Jakobsen J, Bahre A, et al
    Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.
    Front Oncol. 2021;11:672262.
    PubMed         Abstract available

  16. XIAO J, Gong L, Xiao M, He D, et al
    LINC00467 Promotes Tumor Progression via Regulation of the NF-kb Signal Axis in Bladder Cancer.
    Front Oncol. 2021;11:652206.
    PubMed         Abstract available


    Front Surg

  17. GENG Z, Geng Q
    Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis.
    Front Surg. 2021;8:636791.
    PubMed         Abstract available


    Int J Clin Pract

  18. KARKIN K, Izol V, Kaplan M, Deger M, et al
    Demonstration of Advanced Glycation End product (AGE) Expression in Bladder Cancer Tissue in Type 2 Diabetic and Non-diabetic Patients and the Relationship between AGE Accumulation and Endoplasmic Reticulum Stress (ERS) with Bladder Cancer.
    Int J Clin Pract. 2021 Jun 13:e14526. doi: 10.1111/ijcp.14526.
    PubMed         Abstract available

  19. CULPAN M, Keser F, Acar HC, Otunctemur A, et al
    Impact of delay in cystoscopic surveillance on recurrence and progression rates in non-muscle invasive bladder cancer patients during COVID-19 pandemic.
    Int J Clin Pract. 2021 Jun 12:e14490. doi: 10.1111/ijcp.14490.
    PubMed         Abstract available


    Intern Med

  20. KAMAKURA M, Okazaki A, Ito K, Kin F, et al
    Concomitant Pulmonary and Cerebral Tumor Embolism and Intracardiac Metastasis from Bladder Cancer.
    Intern Med. 2021 Jun 12. doi: 10.2169/internalmedicine.6765.
    PubMed         Abstract available


    J Cancer Res Ther

  21. KIM DK, Kim YH, Lee HY, Lee S, et al
    Diagnostic accuracy of Raman spectroscopy for the diagnosis of bladder cancer: A systematic review and meta-analysis.
    J Cancer Res Ther. 2021;17:426-433.
    PubMed         Abstract available

  22. CULPAN M, Turan T, Ozkanli SS, Zenginkinet T, et al
    Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer.
    J Cancer Res Ther. 2021;17:434-442.
    PubMed         Abstract available

  23. KOCAK SY, Kudu A, Apaydin S
    Bacillus Calmette-Guerin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer.
    J Cancer Res Ther. 2021;17:609-612.
    PubMed         Abstract available


    JGH Open

  24. ASATANI S, Kanda T, Honda M, Ishii T, et al
    Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.
    JGH Open. 2021;5:722-724.
    PubMed         Abstract available


    Nitric Oxide

  25. SEYYEDSALEHI MS, Mohebbi E, Sasanfar B, Toorang F, et al
    Dietary N-nitroso compounds intake and bladder cancer risk: A systematic review and meta-analysis.
    Nitric Oxide. 2021;115:1-7.
    PubMed         Abstract available


    Scand J Urol

  26. THOMSEN JA, Nielsen Dominiak H, Lindgren MS, Jensen JB, et al
    Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients.
    Scand J Urol. 2021 Jun 14:1-6. doi: 10.1080/21681805.2021.1938664.
    PubMed         Abstract available


    Urology

  27. CHAPPIDI MR, Welty C, Choi W, Meng MV, et al
    Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
    Urology. 2021 Jun 9. pii: S0090-4295(21)00473.
    PubMed         Abstract available


    World J Urol

  28. BREE KK, Hensley PJ, Brooks N, Matulay J, et al
    Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center.
    World J Urol. 2021 Jun 12. pii: 10.1007/s00345-021-03755.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: